Azurity Pharmaceuticals Receives FDA Approval for Lamlique™ (lamotrigine) oral suspension
Woburn, MA, Sept. 28, 2026 (GLOBE NEWSWIRE) -- Azurity Pharmaceuticals, a privately held global pharmaceutical company dedicated to redefining medicine for the real world, today announced that the U.S. Food and Drug Administration (FDA) has approved …